文献速递主动脉疾病

新型夹层专用覆膜支架预防慢性B型主动脉夹层胸主动脉腔内修复术后远端支架诱导新发破口的早期经验

Early Experience With a Novel Dissection-Specific Stent-Graft to Prevent Distal Stent-Graft-Induced New Entry Tears After Thoracic Endovascular Repair of Chronic Type B Aortic Dissections.
PubMed 文献 · Ann Vasc Surg · 2021-11-14

回顾性单中心队列研究纳入2017年1月1日至2020年1月31日接受新型夹层专用覆膜支架(DSSG)行胸主动脉腔内修复(TEVAR)的慢性B型主动脉夹层(CTBAD)患者16例,技术成功率96%,30天内1例死于逆行A型夹层伴心包填塞,中位影像随访17个月期间1例发生远端支架诱导新发破口(dSINE),结论认为该支架安全可行、中期效果有前景,但需更长期随访。

要点

  • 16例CTBAD患者行DSSG-TEVAR,技术成功率96%,30天内1例死于逆行A型夹层伴心包填塞。
  • 中位影像随访17个月,1例于术后4个月发生dSINE;30天卒中、脊髓缺血和再干预率均为0%。
  • 随访中9例完全假腔血栓形成、6例部分血栓形成,无治疗段直径增大,7例稳定、8例最大横径减小。

核心结论

  • 在CTBAD中应用低径向力的新型DSSG行TEVAR安全可行,早期真实世界经验显示中期效果有前景,dSINE或非计划再干预率低且主动脉重塑满意,但需更长期随访后才能得出明确结论。

研究设计与样本

  • 回顾性单中心队列研究,纳入2017年1月1日至2020年1月31日所有因CTBAD使用DSSG行TEVAR的患者,共16例(男13例、女3例),中位年龄66岁(范围31-79岁)。
  • DSSG为基于Cook Zenith Alpha Thoracic平台改良的覆膜支架,无近端倒钩,定制加长主体并显著渐细,第二、三远端Z支架内置于内部以避免金属骨架接触夹层膜并降低径向力,最远端支架移除形成远端30 mm无支撑Dacron移植物。

主要发现

  • 16例中6例(38%)存在潜在结缔组织病;中位渐细10 mm(范围4-21 mm),中位长度270 mm(范围210-380 mm)。
  • 中位影像随访17个月(范围1-31个月)期间1例于术后4个月发生dSINE;中位生存随访23个月(范围2-35个月)期间1例晚期死于创伤性脑损伤,无主动脉相关死亡。
  • 完全假腔血栓形成9例,其余6例为部分假腔血栓形成;治疗段无直径增大,系列测量显示最大横径稳定7例、减小8例。

局限性

  • 原文结论指出需要更长期随访才能得出明确结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim was to report short and mid-term outcomes of a novel, investigational, dissection-specific stent-graft (DSSG), specifically designed to address the features of chronic type B aortic dissection (CTBAD) and reduce the risk of distal stent-graft-induced new entry tears (dSINE). MATERIALS AND METHODS: A retrospective single center cohort study of all patients undergoing TEVAR with the DSSG for CTBAD from January 1, 2017 to January 31, 2020. The DSSG, which is a modified stent-graft based on the Cook Zenith Alpha Thoracic platform, has no proximal barbs, and a customized longer body length with substantial taper. The second and third distal Z-stents are sited internally to avoid any contact of the metal skeleton with the dissection membrane and have reduced radial force, while the most distal stent was removed creating a distal 30 mm unsupported Dacron graft. RESULTS: Sixteen patients (13 males, 3 females) with a median age of 66 years (range 31-79 years) underwent elective TEVAR of CTBAD using the DSSG. Six patients (38%) had an underlying connective tissue disorder. The median tapering was 10 mm (range 4 mm-21 mm) and median length 270 mm (range 210-380 mm). Technical success was achieved in all but one case (96%). One patient died within 30 days, due to retrograde type A dissection with cardiac tamponade. The 30-day rate of stroke, spinal cord ischemia, and re-interventions was 0%. After median imaging follow-up time of 17 months (range 1-31 months), one patient developed a dSINE 4 months after the index procedure. After median survival follow-up of 23 months (range 2-35 months), one late death occurred due to traumatic brain injury, while no aortic-related death occurred during follow-up. Complete false lumen (FL) thrombosis was achieved in 9 patients while the remaining 6 showed partial FL thrombosis. No instances of diameter increase at the level oftreated aortic segment were noted with serial measurements showing either stable (n = 7) or decreased (n = 8) maximal transverse diameter. CONCLUSIONS: Use of a novel DSSG with low radial force for TEVAR in the setting of CTBAD is safe and feasible. This early real-world experience shows promising mid-term effectiveness with low rates of dSINE or unplanned re-interventions and satisfactory aortic remodeling during follow-up. Longer follow-up is needed, however, before any firm conclusions can be drawn.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Burdess A, D'Oria M, Mani K, et al. Early Experience With a Novel Dissection-Specific Stent-Graft to Prevent Distal Stent-Graft-Induced New Entry Tears After Thoracic Endovascular Repair of Chronic Type B Aortic Dissections. Ann Vasc Surg. 2021. PMID: 34785340. doi:10.1016/j.avsg.2021.10.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。